Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma

Biochemical and Biophysical Research Communications

Volumn 386, Issue 1, 2009, Pages 181-185

  Liu, Xiaojin ^a   Li, Mingcai ^a   Wu, Yan ^a   Zhou, Yanchun ^a   Zeng, Liangming ^a   Huang, Tian ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Allergic inflammation; Antibody; Asthma; Eosinophils; Interleukin 33; Th2 cytokines

Indexed keywords

ANTIASTHMATIC AGENT; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 33 ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; NEUTRALIZING ANTIBODY; OVALBUMIN; UNCLASSIFIED DRUG;

AIRWAY CONSTRICTION; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; EOSINOPHIL COUNT; FEMALE; HISTOPATHOLOGY; IMMUNOGLOBULIN PRODUCTION; LUNG LAVAGE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROVOCATION TEST; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN E; INTERLEUKINS; MICE; MICE, INBRED BALB C; OVALBUMIN; PNEUMONIA; TH1 CELLS; TH2 CELLS;

MURINAE; MUS;

EID: 67649207586     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.008     Document Type: Article

References (36)

1. Holgate S.T. Novel targets of therapy in asthma. Curr. Opin. Pulm. Med. 15 (2009) 63-71
2. Bjermer L., and Diamant Z. Complementary therapy in asthma: inhaled corticosteroids and what?. Curr. Opin. Pulm. Med. 15 (2009) 46-51
3. Holgate S.T., and Polosa R. Treatment strategies for allergy and asthma. Nat. Rev. Immunol. 8 (2008) 218-230
4. Yang G., Volk A., Petley T., Emmell E., Giles-Komar J., Shang X., Li J., Das A.M., Shealy D., Griswold D.E., and Li L. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 28 (2004) 224-232
5. Holgate S.T. Epithelium dysfunction in asthma. J. Allergy Clin. Immunol. 120 (2007) 1233-1244 quiz 1245-1236.
6. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., and Kastelein R.A. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23 (2005) 479-490
7. Allakhverdi Z., Smith D.E., Comeau M.R., and Delespesse G. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179 (2007) 2051-2054
8. Iikura M., Suto H., Kajiwara N., Oboki K., Ohno T., Okayama Y., Saito H., Galli S.J., and Nakae S. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab. Invest. 87 (2007) 971-978
9. Ali S., Huber M., Kollewe C., Bischoff S.C., Falk W., and Martin M.U. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. USA 104 (2007) 18660-18665
10. Hayakawa H., Hayakawa M., Kume A., and Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J. Biol. Chem. 282 (2007) 26369-26380
11. Ho L.H., Ohno T., Oboki K., Kajiwara N., Suto H., Iikura M., Okayama Y., Akira S., Saito H., Galli S.J., and Nakae S. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J. Leukoc. Biol. 82 (2007) 1481-1490
12. Moulin D., Donze O., Talabot-Ayer D., Mezin F., Palmer G., and Gabay C. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40 (2007) 216-225
13. Komai-Koma M., Xu D., Li Y., McKenzie A.N., McInnes I.B., and Liew F.Y. IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol. 37 (2007) 2779-2786
14. Suzukawa M., Iikura M., Koketsu R., Nagase H., Tamura C., Komiya A., Nakae S., Matsushima K., Ohta K., Yamamoto K., and Yamaguchi M. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 181 (2008) 5981-5989
15. Cherry W.B., Yoon J., Bartemes K.R., Iijima K., and Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121 (2008) 1484-1490
16. Suzukawa M., Koketsu R., Iikura M., Nakae S., Matsumoto K., Nagase H., Saito H., Matsushima K., Ohta K., Yamamoto K., and Yamaguchi M. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab. Invest. 88 (2008) 1245-1253
17. Pecaric-Petkovic T., Didichenko S.A., Kaempfer S., Spiegl N., and Dahinden C.A. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113 (2009) 1526-1534
18. Kurowska-Stolarska M., Kewin P., Murphy G., Russo R.C., Stolarski B., Garcia C.C., Komai-Koma M., Pitman N., Li Y., McKenzie A.N., Teixeira M.M., Liew F.Y., and Xu D. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 181 (2008) 4780-4790
19. Kondo Y., Yoshimoto T., Yasuda K., Futatsugi-Yumikura S., Morimoto M., Hayashi N., Hoshino T., Fujimoto J., and Nakanishi K. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 20 (2008) 791-800
20. Oshikawa K., Yanagisawa K., Tominaga S., and Sugiyama Y. Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin. Exp. Allergy 32 (2002) 1520-1526
21. Kwak Y.G., Song C.H., Yi H.K., Hwang P.H., Kim J.S., Lee K.S., and Lee Y.C. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest. 111 (2003) 1083-1092
22. El Gazzar M., El Mezayen R., Marecki J.C., Nicolls M.R., Canastar A., and Dreskin S.C. Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int. Immunopharmacol. 6 (2006) 1135-1142
23. Smithgall M.D., Comeau M.R., Yoon B.R., Kaufman D., Armitage R., and Smith D.E. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 20 (2008) 1019-1030
24. Lee J.J., Dimina D., Macias M.P., Ochkur S.I., McGarry M.P., O'Neill K.R., Protheroe C., Pero R., Nguyen T., Cormier S.A., Lenkiewicz E., Colbert D., Rinaldi L., Ackerman S.J., Irvin C.G., and Lee N.A. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305 (2004) 1773-1776
25. Justice J.P., Crosby J., Borchers M.T., Tomkinson A., Lee J.J., and Lee N.A. CD4(+) T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. Am. J. Physiol. Lung Cell Mol. Physiol. 282 (2002) L1066-1074
26. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., Zhang Y., and Elias J.A. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103 (1999) 779-788
27. Finkelman F.D., and Urban Jr. J.F. The other side of the coin: the protective role of the TH2 cytokines. J. Allergy Clin. Immunol. 107 (2001) 772-780
28. Seder R.A., Paul W.E., Davis M.M., and Fazekas de St Groth B. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 176 (1992) 1091-1098
29. Pawankar R., Okuda M., Yssel H., Okumura K., and Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99 (1997) 1492-1499
30. Dabbagh K., Takeyama K., Lee H.M., Ueki I.F., Lausier J.A., and Nadel J.A. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J. Immunol. 162 (1999) 6233-6237
31. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., and Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183 (1996) 195-201
32. Cocks B.G., de Waal Malefyt R., Galizzi J.P., de Vries J.E., and Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol. 5 (1993) 657-663
33. Chomarat P., and Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int. Rev. Immunol. 17 (1998) 1-52
34. Emson C.L., Bell S.E., Jones A., Wisden W., and McKenzie A.N. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J. Exp. Med. 188 (1998) 399-404
35. Nadler M.J., Matthews S.A., Turner H., and Kinet J.P. Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function. Adv. Immunol. 76 (2000) 325-355
36. Kawakami T., and Galli S.J. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2 (2002) 773-786